Le Lézard
Classified in: Covid-19 virus
Subject: Lawsuit

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fox Corporation's Directors and Officers for Breach of Fiduciary Duties ? FOX, FOXA


Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of Fox Corporation ("Fox") (NASDAQ: FOX, FOXA) breached their fiduciary duties to Fox and its shareholders. If you are a Fox shareholder, you are encouraged to contact attorney Joe Pettigrew for additional information at (844) 818-6982, or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether members of Fox's board of directors or senior management failed to manage Fox in an acceptable manner, in breach of their fiduciary duties, and whether Fox and its shareholders have suffered damages as a result.

On February 4, 2021, Smartmatic USA Corporation ("Smartmatic") filed a defamation lawsuit against Fox, alleging that Smartmatic suffered severe harm after numerous Fox News on-air personalities made misrepresentations about Smartmatic's business in the wake of the November 2020 presidential election. Fox News personalities also made repeated misstatements about the nature and severity of the COVID-19 pandemic.

What You Can Do

If you are a Fox shareholder, you may have legal claims against Fox's directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.

Attorney Advertising


These press releases may also interest you

at 00:47
TRADING STATEMENT FOR THE SIX MONTHS ENDING 31 DECEMBER 2022 Sasol shareholders are advised that for the six months ending 31 December 2022 (2023 financial half year) earnings per share (EPS) and headline earnings per share (HEPS) are expected to...

at 00:01
ATTOM, a leading curator of real estate data nationwide for land and property data, today released a Special Housing Risk Report spotlighting county-level housing markets around the United States that are more or less vulnerable to declines, based on...

at 00:00
As a psychologist in rural West Virginia during the pandemic, Don Worth, Ph.D. was surprised that many of his patients got better during the stay-at-home orders, and yet when restrictions were lifted, they drifted back to old routines and their...

30 nov 2022
IVERIC bio, Inc. (the "Company"), today announced the pricing of an upsized underwritten public offering of 13,350,000 shares of its common stock at a price to the public of $22.50 per share, less underwriting discounts and commissions. In addition,...

30 nov 2022
Rubicon Organics Inc. ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce the publication of its second annual Environmental, Social and...

30 nov 2022
Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") , a publicly traded special purpose acquisition company ("SPAC") formed for the...



News published on 27 september 2022 at 20:55 and distributed by: